Qingdao Vland Biotech INC. (SHA:603739)

Market Cap	3.10B -21.9%
Revenue (ttm)	1.45B +4.0%
Net Income	70.94M -15.1%
EPS	0.29 -12.6%
Shares Out	253.03M
PE Ratio	42.27
Forward PE	34.97
Dividend	0.10 (0.82%)
Ex-Dividend Date	May 29, 2026

Volume	10,369,174
Open	11.75
Previous Close	11.85
Day's Range	11.70 - 12.60
52-Week Range	10.68 - 18.41
Beta	0.53
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHA:603739

Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, food probiotics, environmental microorganisms, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated, and poultry and swine vaccines, as well as egg yolk antibodies; ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 1,522
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603739

Financial Performance

In 2025, SHA:603739's revenue was 1.37 billion, an increase of 3.43% compared to the previous year's 1.32 billion. Earnings were 69.81 million, an increase of 11.45%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 5, 2026

Data Sources Report a data error